Lantheus Holdings Inc (LNTH)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO:
Mary Anne Heino
Employees:
488
331 TREBLE COVE ROAD, NORTH BILLERICA, MA 01862
978 671-8001

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The company products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. It operates through the following segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sell its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 2007 and is headquartered in North Billerica, MA.

Data derived from most recent annual or quarterly report
Market Cap 1.644 Billion Shares Outstanding67.691 Million Avg 30-day Volume 335.67 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.26
Price to Revenue4.2409 Debt to Equity0.3441 EBITDA35.665 Million
Price to Book Value2.74 Operating Margin1.2599 Enterprise Value1.56 Billion
Current Ratio2.607 EPS Growth-1.323 Quick Ratio1.979
1 Yr BETA 1.1909 52-week High/Low 31.6 / 15.54 Profit Margin-2.2865
Operating Cash Flow Growth-78.8135 Altman Z-Score3.0978 Free Cash Flow to Firm -423.658 Million
View SEC Filings from LNTH instead.

View recent insider trading info

Funds Holding LNTH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LNTH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

16.6 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SABENS ANDREA CHIEF ACCOUNTING OFFICER

  • Officer
61,102 2022-01-18 7

HEINO MARY ANNE PRESIDENT & CEO

  • Officer
  • Director
660,749 2022-01-03 6

YAO YING VIVIAN CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2021-12-15 1

MARSHALL ROBERT J. JR. CFO AND TREASURER

  • Officer
127,007 2021-10-18 3

MONTAGUT ETIENNE CHIEF BUSINESS OFFICER

  • Officer
83,594 2021-10-18 4

NIEDZWIECKI DANIEL SEE REMARKS

  • Officer
57,060 2021-08-16 3

BOLLA JOHN J. CHIEF OPERATIONS OFFICER

  • Officer
102,440 2021-06-16 3

LENO SAM R

  • Director
49,297 2021-05-10 2

MARKISON BRIAN A

  • Director
47,788 2021-05-10 1

THRALL JAMES H

  • Director
28,380 2021-05-10 1

MCHUGH JULIE

  • Director
31,570 2021-05-10 2

PRUDEN GARY J

  • Director
28,765 2021-05-10 1

BER GERARD

  • Director
31,800 2021-05-10 1

MAEUSLI HEINZ CHRISTOPH

  • Director
24,724 2021-05-10 7

ROBERTSON A FREDERICK

  • Director
No longer subject to file 2021-04-28 1

WALKER CAROL SENIOR VICE PRESIDENT, QUALITY

  • Officer
76,203 2021-04-28 1

DUFFY MICHAEL P SVP AND GENERAL COUNSEL

  • Officer
109,472 2021-04-16 3

MOLNAR ISTVAN CHIEF MEDICAL OFFICER

  • Officer
58,950 2021-03-04 1

BLANCHFIELD PAUL CHIEF COMMERCIAL OFFICER

  • Officer
60,329 2021-03-04 1

SCHAFFER DERACE L

  • Director
25,089 2020-03-03 0

PUCEL KENNETH

  • Director
21,359 2020-03-03 0

CLEMMER JAMES C

  • Director
62,082 2020-03-03 0

ORLANDI CESARE CHIEF MEDICAL OFFICER

  • Officer
68,483 2019-07-08 0

CROWLEY JOHN W. CFO

  • Officer
161,825 2018-04-26 0

HEALEY TIMOTHY G SVP, COMMERCIAL

  • Officer
85,658 2018-03-05 0

BURGSTAHLER DAVID F

  • Director
No longer subject to file 2017-09-07 0

DAWES WILLIAM C. JR. VP, MFG & OPS

  • Officer
111,581 2017-09-01 0

AVISTA CAPITAL PARTNERS GP, LLC

AVISTA CAPITAL PARTNERS, L.P.

AVISTA CAPITAL PARTNERS (OFFSHORE), L.P.

ACP-LANTERN CO-INVEST, LLC

  • 10% Owner
No longer subject to file 2017-08-14 0

VENKATARAMAN SRIRAM

  • Director
  • 10% Owner
12,293,599 2017-03-17 0

BAKEWELL JOHN K CFO AND TREASURER

  • Officer
No longer subject to file 2015-12-31 0

BAILEY JEFFREY ALLEN CEO AND PRESIDENT

  • Officer
  • Director
No longer subject to file 2015-08-31 0

O'NEILL PATRICK

  • Director
14,382 2015-06-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SABENS ANDREA - Officer CHIEF ACCOUNTING OFFICER

2022-01-20 16:30:25 -0500 2022-01-18 S 1,242 $26.93 d 61,102 direct 2.9727 2.9727 2 0.0 1

HEINO MARY ANNE - Director - Officer PRESIDENT & CEO

2022-01-05 16:43:12 -0500 2022-01-03 S 14,100 $28.61 d 660,749 direct -2.643 -4.055 0.0 1 -4.4533 3

SABENS ANDREA - Officer CHIEF ACCOUNTING OFFICER

2021-12-17 16:30:18 -0500 2021-12-15 S 1,242 $26.72 d 62,344 direct 3.3067 9.0843 9.375 5 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LANTHEUS HOLDINGS INC LNTH 2022-01-28 19:45:03 UTC -0.1905 0.2605 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 19:15:03 UTC -0.1905 0.2605 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 18:45:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 18:15:04 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 17:45:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 17:15:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 16:45:04 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 16:15:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 15:45:04 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 15:15:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 14:45:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 14:15:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 13:45:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 13:15:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-28 12:45:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-27 22:15:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-27 21:45:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-27 21:15:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-27 20:45:03 UTC -0.289 0.359 2900000
LANTHEUS HOLDINGS INC LNTH 2022-01-27 20:15:04 UTC -0.289 0.359 2900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund LNTH -16979.0 shares, $-397138.81 2021-10-31 N-PORT

Elevate your investments